Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Interventional Technologies (IVT) was a pioneering medical device company focused on the field of interventional cardiology. Headquartered in San Diego, the company developed and commercialized the Cutting Balloon, a specialized angioplasty device featuring longitudinal atherotomes designed to score plaque and facilitate vessel expansion. This technology was particularly effective in treating complex, calcified lesions and reducing the risk of vessel recoil and restenosis compared to standard balloon angioplasty. Beyond the Cutting Balloon, IVT developed the Infiltrator catheter, a device designed for the intramural delivery of therapeutic agents directly into the vessel wall. In 2001, Boston Scientific acquired the company for approximately $600 million to bolster its position in the vascular intervention market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Interventional Technologies.